Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration

INTRODUCTION: SB11 (Byooviz™) is a ranibizumab biosimilar that acts as a vascular endothelial growth factor (VEGF)-A inhibitor. Stability data for unopened SB11 vials at room temperature are limited and no data are available for SB11 withdrawn into syringes (in-use) for intravitreal administration....

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Peter K., Yun, Jihoon, Kim, Soyeon, Kim, Jihyun, Park, Su Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011347/
https://www.ncbi.nlm.nih.gov/pubmed/36607595
http://dx.doi.org/10.1007/s40123-022-00645-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011347/
https://www.ncbi.nlm.nih.gov/pubmed/36607595
http://dx.doi.org/10.1007/s40123-022-00645-1

Ejemplares similares